The pharmaceutical industry is expected to see spending in the sector double in the next few years.
The best pharmaceutical stock in 2017 is set to cash in on the increased spending by taking advantage of the medical marijuana trends.
The pharmaceutical industry is expected to see spending in the sector double in the next few years.
The best pharmaceutical stock in 2017 is set to cash in on the increased spending by taking advantage of the medical marijuana trends.
And it could potentially gain 100% to double your money in the next 12 months...
by Alex McGuire
The big silver price news today is the metal's decline to its lowest level of 2017.
The primary factor behind the drop is the June jobs report, which beat expectations by 23.3%.
But we believe this is just a short-term dip. Here's why silver could rebound to $22 this year...
by Casey Wilson
China's latest solution to its farming crisis is to accumulate as much foreign farmland as possible – especially in America.
And the U.S., with six times more arable land per capita, is the perfect contract farmer...
Is Uber publicly traded?
Retail investors want to know if they can buy Uber stock right now.
by A.J. Bursick
America needs China's help with North Korea right now.
But don't expect the Red Dragon to help without laying out these two demands first.
Demands that Washington isn't likely to accept…
The Dow Jones news today features the latest report of 222,000 jobs added in June while President Trump will be meeting Russian President Vladimir Putin later today.
Dow Jones futures are up 38 points this morning.
by
World stock markets were mostly lower overnight as the marketplace reality sets in that there will be less accommodative monetary policies from the world's major central banks-after nearly a decade of easy-money initiatives.
Higher world government bond market yields this week are also bearish for the global equities markets. U.S. stock indexes are pointed toward narrowly mixed openings when the New York day session begins.
Last week, I showed you how powerful the market's post-crisis "narrative," or its overarching driving theme, can be.
Since the November 2016 election, the narrative has revolved around the administration's "Big Three" initiatives: reduced taxes, reduced regulation, and increased infrastructure spending. It's a heady brew that's driven some 13% in gains since the election, and any news that supported the idea of the "Big Three" sent the markets higher.
But… I also talked about how that narrative could be changing – in a big way.
by David Zeiler
More Bitcoin millionaires are created every time the price of the digital currency jumps up significantly.
But a special few have been Bitcoin millionaires for some time, having purchased large amounts of it years ago at much lower prices. A few of these were early adopters; others were already wealthy individuals who could afford to buy millions of dollars' worth of Bitcoin.
These are the top seven Bitcoin millionaires - and how much we think each is worth today...
Our expert has put together a set of biotech-buying guidelines to make finding the best biotech stocks to buy simple and profitable.
Using his guidelines, we've found three biotech stocks about to skyrocket.
One of them on our list could gain as much as 270% in the next 12 months...